1731. Rezafungin Activity against Candida spp. and Aspergillus spp. Isolates Causing Invasive Infections Worldwide in 2021

BACKGROUND: Rezafungin (RZF) is a once-weekly echinocandin (ECH) with a long half-life and front-loaded drug exposure. RZF is in development to treat candidemia and invasive candidiasis and prevent invasive fungal disease caused by Candida, Aspergillus, and Pneumocystis spp. We evaluated the in vitr...

Descripción completa

Detalles Bibliográficos
Autores principales: Carvalhaes, Cecilia G, Rhomberg, Paul, Strand, Greg, Klauer, Abby L, Castanheira, Mariana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752930/
http://dx.doi.org/10.1093/ofid/ofac492.1361

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752930/
http://dx.doi.org/10.1093/ofid/ofac492.1361

Ejemplares similares